RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the Authors. The authors have independently identified an error in the formula that was utilized to calcul...

Full description

Saved in:
Bibliographic Details
Published inGynecologic oncology Vol. 183; pp. 78 - 84
Main Authors Riedinger, Courtney J., Barrington, David A., Nagel, Christa I., Khadraoui, Wafa K., Haight, Paulina J., Tubbs, Crystal, Backes, Floor J., Cohn, David E., O'Malley, David M., Copeland, Larry J., Chambers, Laura M.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.04.2024
Online AccessGet full text

Cover

More Information
Summary:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the Authors. The authors have independently identified an error in the formula that was utilized to calculate the Quality Adjusted Life Years which invalidates the data and the conclusion of the paper. The authors have contacted the journal requesting to retract the article. Apologies are offered to the readers of the journal for any confusion or inconvenience that may have resulted from the publication of this article.
Bibliography:retraction
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Correction/Retraction-3
ISSN:0090-8258
1095-6859
1095-6859
DOI:10.1016/j.ygyno.2024.03.020